Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

April 15, 2026; Volume 23,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Bai, Yating

    1. Open Access
      Design principles of nanomaterials for cancer immunotherapy: a mechanistic framework across the cancer immunity cycle
      Yating Bai, Zhihao Lan, Nana Feng, Zhanzhan Zhang and Yang Liu
      Cancer Biology & Medicine April 2026, 23 (4) 541-558; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0737
  2. Busscher, Henk J.

    1. Open Access
      Poor prognosis outcome tumors, bacteria-infected tumors and nanodrugs: current evidence and hypotheses towards a paradigm change for treatment
      Henk J. Busscher, David W. Grainger, JinPu Yu and Da-Yuan Wang
      Cancer Biology & Medicine April 2026, 23 (4) 527-540; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0748
  3. Cao, Qiqi

    1. Open Access
      From diagnostic marker-to-therapeutic modality: emerging paradigms in tumor biomineralization
      Fan Liu, Qiqi Cao, Qinglan Chen, Zimo Dong, Anru Wang, Negar Hosseini, Han Han, Yuxuan Shen, Yutong Wu, Liyan Miao and Huabing Chen
      Cancer Biology & Medicine April 2026, 23 (4) 504-526; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0008
  4. Chen, Huabing

    1. Open Access
      From diagnostic marker-to-therapeutic modality: emerging paradigms in tumor biomineralization
      Fan Liu, Qiqi Cao, Qinglan Chen, Zimo Dong, Anru Wang, Negar Hosseini, Han Han, Yuxuan Shen, Yutong Wu, Liyan Miao and Huabing Chen
      Cancer Biology & Medicine April 2026, 23 (4) 504-526; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0008
  5. Chen, Jun

    1. Open Access
      Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies
      Hongyu Chu, Jun Chen, Sheyu Ye, Xuedong Fang, Na Shen and Zhaohui Tang
      Cancer Biology & Medicine April 2026, 23 (4) 453-460; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0512
  6. Chen, Qinglan

    1. Open Access
      From diagnostic marker-to-therapeutic modality: emerging paradigms in tumor biomineralization
      Fan Liu, Qiqi Cao, Qinglan Chen, Zimo Dong, Anru Wang, Negar Hosseini, Han Han, Yuxuan Shen, Yutong Wu, Liyan Miao and Huabing Chen
      Cancer Biology & Medicine April 2026, 23 (4) 504-526; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0008
  7. Chu, Hongyu

    1. Open Access
      Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies
      Hongyu Chu, Jun Chen, Sheyu Ye, Xuedong Fang, Na Shen and Zhaohui Tang
      Cancer Biology & Medicine April 2026, 23 (4) 453-460; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0512
  8. Dong, Zimo

    1. Open Access
      From diagnostic marker-to-therapeutic modality: emerging paradigms in tumor biomineralization
      Fan Liu, Qiqi Cao, Qinglan Chen, Zimo Dong, Anru Wang, Negar Hosseini, Han Han, Yuxuan Shen, Yutong Wu, Liyan Miao and Huabing Chen
      Cancer Biology & Medicine April 2026, 23 (4) 504-526; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0008
  9. Fang, Xuedong

    1. Open Access
      Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies
      Hongyu Chu, Jun Chen, Sheyu Ye, Xuedong Fang, Na Shen and Zhaohui Tang
      Cancer Biology & Medicine April 2026, 23 (4) 453-460; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0512
  10. Feng, Nana

    1. Open Access
      Design principles of nanomaterials for cancer immunotherapy: a mechanistic framework across the cancer immunity cycle
      Yating Bai, Zhihao Lan, Nana Feng, Zhanzhan Zhang and Yang Liu
      Cancer Biology & Medicine April 2026, 23 (4) 541-558; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0737
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top
Previous

In this issue

Cancer Biology & Medicine: 23 (4)
Cancer Biology & Medicine
Vol. 23, Issue 4
15 Apr 2026
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire